NEUROTECH INTERNATIONAL LIMITED (NTI)
Latest AI Signal: SELL
Status: AGING
Days Old: 6
Confidence: 75.00%
Date: 15-05-2026
Price: $0.011
Last Price: $0.012
Post-Signal Low Price: $0.012
Latest NEUROTECH INTERNATIONAL LIMITED(NTI) News
01 Mar 2022, 10:18 AM
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. But while the
Chart available once enough post-signal price data is available.
Sell Confidence High
AI Confidence - 75.00 % model confidence
Business Overview
Neurotech International Limited is a medical technology company focused on developing and commercializing innovative neurostimulation devices primarily targeting neurological disorders such as epilepsy and chronic pain. The company operates in a niche market with emerging products but faces significant competition and regulatory challenges in global markets.
Financial Analysis
| Cash Flow | Weak |
| Debt | Moderate |
| Profitability | Weak |
| Revenue Trend | Downtrend |
Technical Analysis
| Trend | Bearish |
| Momentum | Weak |
| RSI Signal | Oversold |
| Support Level | $ 0.0100 |
| Resistance Level | $ 0.0150 |
Valuation
Valuation - Undervalued
The stock is trading at a low price reflecting market skepticism, but valuation multiples suggest potential upside if operational execution improves.
Catalysts
• Potential regulatory approvals or clinical trial successes
• Strategic partnerships or licensing agreements
• Improvement in revenue and cash flow metrics
• Positive market reception of new product launches
Recommendation
Action - Sell
Timeframe - Short Term
Given the weak financials, bearish technical signals, and high execution risks, the stock is not attractive at current levels despite undervaluation. Investors should avoid or reduce exposure until clearer operational improvements emerge.